View Online
May 7, 2020

ABC Perspective on Health Disparities in Diverse
Populations Published in Circulation Journal

ABC is pleased to announce the publication of a paper entitled, "At the Heart of the Matter: Unmasking and Addressing COVID-19's Toll on Diverse Populations,” authored by ABC Board member Norrisa Haynes, MD, MPH, ABC Member Lisa A. Cooper, MD, MPH, and ABC President Michelle A. Albert, MD, MPH, on behalf of the Association of Black Cardiologists.

News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.

New Angiotensin Studies in COVID-19 Give More Reassurance
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes but suggests possible differential effects of the two drug classes.
FDA Approves Dapagliflozin (Farxiga) for Low-EF Heart Failure
The widely anticipated approval makes dapagliflozin (Farxiga, AstraZeneca) the only drug in its class to be indicated for heart failure in the absence of diabetes.
FOURIER: Evolocumab Follow-up Shows No Cognitive Adverse Effects
The FOURIER pivotal outcomes trial showed no signal of mental harm related to treatment with the PCSK9 inhibitor or to the achievement of very low levels of low-density-lipoprotein cholesterol levels. (FOURIER was sponsored by Amgen, the company that markets evolocumab (Repatha)).
Multisociety Roadmap for Restarting Elective Cardiac Cases
A new consensus document provides guidance on the safe reintroduction of cardiovascular procedures and testing derailed by the COVID-19 pandemic.
AAN 2020: Statins and ICH: New Meta-Analysis
A new meta-analysis has concluded that the benefit of statin therapy in the prevention of ischemic stroke 'greatly exceeds' the risk for intracerebral hemorrhage (ICH).


HHS to Fund Community-Based Patient Outreach in Minority Populations
The funding aims to help traditionally underserved populations access public health
messaging through community-based patient outreach campaigns.
The U.S. Department of Health and Human Services’ Office of Minority Health (OMH) announced a competitive funding opportunity to invest up to $40 million for the development and coordination of a strategic network of national, state, territorial, tribal and local organizations to deliver important COVID-19-related information to racial and ethnic minority, rural and socially vulnerable communities hardest hit by the pandemic. The information network will strengthen efforts to link communities to COVID-19 testing, healthcare and social services and to best share and implement effective response, recovery and resilience strategies.

The three-year initiative will include the development and coordination of a strategic and structured network of organizations that will help mitigate the impact of COVID-19 on racial and ethnic minority communities across the nation. The initiative also includes a national multi-media outreach and education effort.

Applications are due by 6:00 PM Eastern Time on Monday, May 11. Technical assistance will be provided to those who are interested in applying for this cooperative agreement.


ABC’s COVID-19 FAQ Watch Available Now

If you missed this lively and engaging discussion about the epidemiology, clinical, prevention and social aspects of COVID-19 infection in diverse populations from ABC's webcast OR want to review it again, view the archived video.


Items of Interest

Plant-Based Diets for CVD Prevention
How can cardiologists leverage the teachable moment after a cardiac event into dietary changes? In this episode of the AP Cardiology podcast, Kim Williams, MD, former president of the American College of Cardiology, walks Andrew Perry, MD, through the rationale and bedside pearls on how to talk to patients about plant-based diets. Read the transcript or listen to the podcast.
SHIBA & Friends - Talking RACE & Covid-19 with Dr. Dave
Shiba Russell, the Morning Rush Co-anchor on 11Alive, WXIA in Atlanta, interviews David Montgomery, MD, about COVID-19, health disparities and African-Americans during her Facebook Live show. Dr. Montgomery answers viewer questions as well.
Researchers Create mHealth Patch to Monitor COVID-19 Patients at Home
Researchers in Chicago are working on an mHealth wearable that will help providers monitor COVID-19 patients at home. The patch, developed by Northwestern University and the Shirley Ryan AbilityLab, attaches to the throat and monitors lung movement and breathing sounds for coughing and breathing problems associated with the Coronavirus. It uses telemedicine technology initially designed to remotely monitor speech and swallowing in patients recovering from a stroke.
Miscarriage and Maternal Mortality in Pregnant COVID-19 Patients
While previous reports of COVID-19 illness in pregnant women show generally good outcomes, the risk to expecting mothers and their infants isn't zero, researchers said. For example, a pregnant woman in Switzerland delivered a stillborn infant at 19 weeks' gestation after testing positive for COVID-19, reported David Baud, MD, PhD, of the Lausanne University Hospital in Switzerland, and colleagues.
Time For Pharmacist Clinicians To Enhance Engagement In The COVID-19 Fight
Read the latest blog post from Kevin B. Sneed, PharmD, Dean of the University of South Florida College of Pharmacy, who writes about the important role community pharmacies can play in the war against COVID-19 as a result of the Department of Health and Human Services’ recent authorization under the Public Readiness and Emergency Preparedness Act (PREP) that allows licensed pharmacists to order and administer FDA-authorized COVID-19 tests.
Sanofi to Enroll Thousands for Its Coronavirus Vaccine Trials
French drugmaker Sanofi SA said it plans to enroll thousands of subjects globally for trials of an experimental vaccine for the coronavirus it is developing with GlaxoSmithKline Plc, and that it has started to discuss advanced purchases with several countries.
Pfizer, BioNTech dose first U.S. subject with COVID-19 vaccine
Pfizer and BioNTech have begun dosing participants in a U.S. clinical trial of their COVID-19 vaccine candidates. The dose-escalation stage of the trial will enroll up to 360 subjects, initially out of sites in New York and Maryland, working with researchers at NYU Grossman School of Medicine and the University of Maryland School of Medicine to test the vaccine. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week.

Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.

Current Perspectives on Coronavirus 2019 (Covid-19) And Cardiovascular Disease: A White Paper by the JAHA Editors
Co-authored by Daniel Addison (with Ajay K. Gupta , Hani Jneid, Hossein Ardehali, Amelia K. Boehme, Sanket Borgaonkar, Romain Boulestreau, Kevin Clerkin, Nicolas Delarche, Holli A. DeVon, Isabella M. Grumbach, et al.)
Coronavirus Disease 2019 (COVID‐19), caused by the Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020, making it the most lethal pandemic since the Spanish flu of 1918, COVID‐19 may preferentially infect individuals with cardiovascular conditions, is more severe in subjects with cardiovascular comorbidities, may directly or indirectly affect the heart and may interact with cardiovascular medications. In addition, the widespread effects of the pandemic on the global healthcare system affects the routine and emergency cardiac care for patients who are, may be, or are not infected with COVID‐19.
Addressing Sexual Harassment in the #MeToo Era: An Institutional Approach
Co-authored by Sharonne N. Hayes, MD (Charanjit S. Rihal, MD, Nichelle A. Baker, BS, Brian E. Bunkers, MD, Steven J. Buskirk, MD, John N. Caviness, MD, Erin A. Collins, JD, Joseph C. Copa, JD, Sherry L. Hubert, JD, et al.)
Sexual harassment is a particularly pernicious form of harassment that can result in long-lasting psychological damage to victims. In health care, it has deleterious effects on teamwork and communication and may affect patient care. Evidence indicates that harassment in health care centers is not uncommon and has not decreased with time. Beyond reporting and addressing, health care institutions must establish policies that clearly outline the unacceptability of harassing behaviors. Moreover, institutions must have a systematic method to thoroughly investigate allegations of sexual harassment and to impose fair and consistent corrective actions when allegations are substantiated. This article describes Mayo Clinic's approach to this complex problem, including targeted efforts toward developing a culture intolerant of sexually harassing behavior.

Healthy People 2020 Health Disparities Data Widget
The Office of Disease Prevention and Health Promotion (ODPHP), National Center for Health Statistics (NCHS) and the Office of Minority Health (OMH) are pleased to announce the release of a new data search function. The Health Disparities widget is a new way for you to access this health disparities information. The new widget provides an easy way to find health disparities data related to the Healthy People 2020 objectives for the Leading Health Indicators (LHIs).

We LOVE to LEARN how our ABC Members are making a difference! Please Share. Giving a keynote speech? Presenting at a Grand Round? Receiving an Award? Interviewed by the Press? Published in a journal? Presenter or Panelist at a Conference? Graduating? Email Rachel Williams at or please tag or DM us on Facebook, Twitter or Instagram with links/details, so we can spotlight your excellence in our newsletter!


Columbus Batiste, MD, LaPrincess Brewer, MD, and Lisa Cooper, MD, will be among will be among the featured guest speakers at Essence Wellness House — a Virtual Summit: At War With COVID-19 and Health Inequities” on Friday, May 8 from 7 am – 5 pm EDT. The summit will address the impact COVID-19 has on Black communities and what individuals can do to improve their health and vitality. Make sure to register in order to stream their sessions at a computer near you! The summit is free but registration is required here.

Fighting Healthcare Inequities: Defend YOURSELF Against COVID-19!
Dr. Lisa Cooper, Director, Johns Hopkins Center for Health Equity
09:25 AM - 09:55 AM
How To Resolve Grief After COVID-19 Loss; Your Heart Depends On It
Dr. Columbus Batiste, Interventional Cardiologist Dr. Anita Phillips, Therapist...
12:30 PM - 01:00 PM
OPERATION SERVE: How to Serve Your Community Now presented by Walmart
Dr. LaPrincess Brewer, MD, MPH, FACC, FASPC, FACP Esi Eggleston Bracey, Transfor...
02:10 PM - 02:40 PM


VIRTUAL: The Impact of Innovation and IP Rights
on COVID-19 Vaccine Development

Thursday, May 14, 2020 | 10:30 a.m. to 12:00 p.m. ET

The importance of intellectual property (IP) has never been more apparent than it is now as the life sciences industry is working around the clock to eradicate the novel coronavirus. America’s robust patent system has enabled biopharmaceutical companies to accelerate the development of new vaccine candidates and testing of existing treatments at a record speed.

Please join us for a discussion about the critical role of IP for pandemic responsiveness, the importance of fostering public-private partnerships to the innovation ecosystem, and recent proposals which could undermine vaccine access and affordability.

Webex information will be shared with those who RSVP on Wednesday, May 13


Work with nationally recognized research experts and learn more about clinical trial research in ACC’s newly expanded Clinical Trials Research: Upping Your Game Program. Apply for this opportunity by May 30.


The Cardiovascular Digital Health Journal will be published
every other month beginning in July 2020.

Million Hearts® announces a NEW Hospitals & Health Systems Recognition Program that will spotlight clinical entities committed to reducing the impact of heart attacks and strokes. Learn how you can apply below. The first round of applications is due April 30, 2020.


Job Opening | Assistant/Associate Professor of Cardiology

The Department of Medicine, Division of Cardiology at the Morehouse School of Medicine is seeking a BC/BE interventional cardiologist at the assistant or associate professor level.

This position includes practice in a facility with state of the art invasive/interventional and noninvasive laboratories, the region’s only Level 1 Trauma Center and cardiology fellowship training program. Qualified applicants should possess outstanding clinical and interpersonal skills with commitment to teaching and research. Additional skills in echocardiography, nuclear and peripheral imaging is desirable.

Interested applicants should email or send CV to:

Anekwe Onwuanyi, MD, FACC, FHFSA
Chief, Division of Cardiology
720 Westview Drive, S.W.
Atlanta, Georgia 30310
Phone: (404) 616-8804


The National Heart, Lung, and Blood Institute's PRIDE Summer Institute is now accepting applications! There are nine mentored research training programs offering career advancing opportunities for junior-level faculty and research scientists from diverse backgrounds.
Rolling admission until all positions are filled.
**PRIDE is still recruiting for Summer 2020. We are currently working out how to hold sessions if we are unable to do so onsite due to COVID-19. The programs will carry-on. If you are interested you may still apply.


Upcoming Events

March 26th Message Related to the Upcoming 2020 Conference

The current pandemic has prompted the government of the Netherlands to ban all public gatherings before 1 September 2020. As such, ESC Congress 2020 cannot take place in Amsterdam as planned. Instead, the meeting is moving online: “ESC Congress 2020 - Challenging Times, Infinite Possibilities.” Mark your calendars now and join us each day – from Saturday, 29 August to Tuesday, 1 September. Details on free registration will be shared soon.


NMA continues to monitor the evolving impacts of the COVID-19 pandemic. As of April 1st, 2020, NMA Annual Convention and Scientific Assembly remains scheduled for August 1–5 in Atlanta.


This email was sent to ##email## by Association of Black Cardiologists, powered by Powered by Multiview's Content Marketing
Archive | View Online | Unsubscribe | Subscribe